Printer Friendly

ALAMAR BIOSCIENCES ANNOUNCES UNIT SPLIT, COMMON SHARES AND WARRANTS AVAILABLE FOR PURCHASE

 SACRAMENTO, Calif., March 23 /PRNewswire/ -- Alamar Biosciences Inc. (NASDAQ: ALMR), announced today that its common shares and warrants to purchase common shares began trading on NASDAQ. The company's Unit, consisting of one common share and one warrant will remain listed. Trading will be under all three symbols, ALMRU, ALMR and ALMRW, for the Unit, the common shares and the warrant, respectively.
 The common shares opened at $4.50, the warrant at $1.00 and the Unit at $5.50. The Units were originally priced at $5 each in October 1992, during the company's initial public offering.
 Alamar Biosciences Inc. is a research and development company that develops, manufacturers and markets in vitro (outside the body) testing products for hospitals, reference laboratories and other healthcare providers. Alamar also markets alamar Blue(TM), an indicator dye for determining cell viability in research and biotechnology applications. The company recently formed its first nationwide sales force and is currently pursuing numerous agreements with leading diagnostic manufacturers and distributors in key foreign countries.
 -0- 3/23/93
 /CONTACT: Kenneth Miller, chief executive officer of Alamar Biosciences, 916-567-3475; or Elizabeth Truax, 415-986-1591, or Kathy Brunson, 312-266-7800, both of the Financial Relations Board for Alamar Biosciences/
 (ALMR ALMRU ALMRW)


CO: Alamar Biosciences Inc. ST: California IN: MTC SU: OFR

TM -- SF002 -- 9271 03/23/93 12:54 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Mar 23, 1993
Words:221
Previous Article:DECORATOR INDUSTRIES ANNOUNCES STOCK SPLIT AND DIRECTOR APPOINTMENT
Next Article:BELLSOUTH ACQUIRES INTEREST IN FRANCE TELECOM MOBILES DATA; BEGINS CONSTRUCTION OF NETHERLANDS SYSTEM
Topics:


Related Articles
ALAMAR BIOSCIENCES PRODUCES FIRST NON-TOXIC IN VITRO INDICATOR DYE -- EXPECTED TO SIGNIFICANTLY REDUCE TOXICITY TESTING ON ANIMALS
ALAMAR BIOSCIENCES REPORTS FIRST QUARTER EARNINGS
ALAMAR BIOSCIENCES ADDS 3NET SOFTWARE TO GROWING PRODUCT LINE
ALAMAR BIOSCIENCES ANNOUNCES PRIVATE FINANCINGS
ALAMAR BIOSCIENCES RAISES OVER $3.1 MILLION THROUGH PRIVATE FINANCINGS
ALAMAR BIOSCIENCES ANNOUNCES PROPOSED PRIVATE PLACEMENT
ALAMAR BIOSCIENCES REACHES AGREEMENT IN PRINCIPLE WITH SCHERER HEALTHCARE
ALAMAR BIOSCIENCES ANNOUNCES CUTBACKS
ALAMAR BIOSCIENCES, INC. ANNOUNCES PROPOSED BRIDGE FINANCING AND WARRANT SOLICITATION
CORRECTION TO NASDAQ STATEMENTS REGARDING ACCUMED INTERNATIONAL AND ALAMAR BIOSCIENCES(Correction Notice)

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters